Patents by Inventor Jorg Habermann

Jorg Habermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6933298
    Abstract: Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides of formula I. These compounds are found to possess the property of selectively inhibiting collagenase (MMP). They may therefore be useful in prophylaxis and therapy of diseases whose course involves an increased activity of matrix metalloproteinase 13.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: August 23, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Klaus-Ulrich Weithmann, Jörg Habermann, Herbert Kogler, Reinhard Kirsch, Volkmar Wehner
  • Publication number: 20040209868
    Abstract: Compounds of the formula I 1
    Type: Application
    Filed: May 11, 2004
    Publication date: October 21, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Olaf Ritzeler, Hans Ulrich Stilz, Bernhard Neises, Gerhard Jaehne, Jorg Habermann
  • Publication number: 20030229103
    Abstract: Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides of formula I. These compounds are found to possess the property of selectively inhibiting collagenase (MMP). They may therefore be useful in prophylaxis and therapy of diseases whose course involves an increased activity of matrix metalloproteinase 13.
    Type: Application
    Filed: December 9, 2002
    Publication date: December 11, 2003
    Inventors: Klaus-Ulrich Weithmann , Jorg Habermann , Herbert Kogler , Reinhard Kirsch , Volkmar Wehner
  • Publication number: 20030119820
    Abstract: Compounds of the formula I 1
    Type: Application
    Filed: October 4, 2002
    Publication date: June 26, 2003
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Olaf Ritzeler, Hans Ulrich Stilz, Bernhard Neises, Gerhard Jaehne, Jorg Habermann
  • Patent number: 6358978
    Abstract: Compounds of formula I are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of NF&kgr;B is involved.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: March 19, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Olaf Ritzeler, Hans Ulrich Stilz, Bernhard Neises, William Jerome Bock, Jr., Armin Walser, Gary A. Flynn, Jörg Habermann, Gerhard Jähne